Diamond Hill Capital Management Inc. Buys Shares of 475,216 Bath & Body Works, Inc. (NYSE:BBWI)

Diamond Hill Capital Management Inc. bought a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund bought 475,216 shares of the company's stock, valued at approximately $15,169,000. Diamond Hill Capital Management Inc. owned about 0.22% of Bath & Body Works at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Envestnet Portfolio Solutions Inc. raised its holdings in Bath & Body Works by 5.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 5,571 shares of the company's stock worth $279,000 after purchasing an additional 277 shares in the last quarter. CWM LLC lifted its stake in shares of Bath & Body Works by 6.6% in the 2nd quarter. CWM LLC now owns 5,072 shares of the company's stock valued at $198,000 after purchasing an additional 314 shares in the last quarter. Northwest Bank & Trust Co lifted its stake in shares of Bath & Body Works by 2.5% in the 1st quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company's stock worth $655,000 after acquiring an additional 315 shares during the period. DekaBank Deutsche Girozentrale grew its stake in shares of Bath & Body Works by 1.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company's stock worth $1,560,000 after acquiring an additional 322 shares during the last quarter. Finally, Citizens & Northern Corp boosted its stake in Bath & Body Works by 1.7% during the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company's stock worth $1,151,000 after acquiring an additional 487 shares during the last quarter. Hedge funds and other institutional investors own 95.14% of the company's stock.

Insider Activity at Bath & Body Works

In other news, CEO Gina Boswell bought 6,000 shares of Bath & Body Works stock in a transaction dated Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the purchase, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.27% of the company's stock.

Bath & Body Works Stock Up 0.2 %

Shares of Bath & Body Works stock traded up $0.05 during trading on Tuesday, reaching $31.56. 3,349,974 shares of the stock were exchanged, compared to its average volume of 3,829,171. The firm has a market cap of $6.92 billion, a price-to-earnings ratio of 7.67, a price-to-earnings-growth ratio of 0.95 and a beta of 1.79. The stock's fifty day moving average is $30.02 and its 200 day moving average is $36.77. Bath & Body Works, Inc. has a 1 year low of $26.20 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.35 by $0.02. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. Equities analysts forecast that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 2.53%. The ex-dividend date is Friday, November 22nd. Bath & Body Works's dividend payout ratio (DPR) is presently 19.37%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Evercore ISI cut their price target on shares of Bath & Body Works from $45.00 to $35.00 and set an "in-line" rating for the company in a report on Wednesday, August 28th. Bank of America decreased their target price on Bath & Body Works from $54.00 to $45.00 and set a "buy" rating for the company in a research note on Thursday, August 29th. Morgan Stanley dropped their price objective on shares of Bath & Body Works from $56.00 to $51.00 and set an "overweight" rating on the stock in a research note on Thursday, September 5th. The Goldman Sachs Group cut their target price on Bath & Body Works from $60.00 to $49.00 and set a "buy" rating on the stock in a report on Thursday, August 29th. Finally, UBS Group dropped their price objective on shares of Bath & Body Works from $52.00 to $38.00 and set a "neutral" rating for the company in a research report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $42.44.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.